OpenAlex
metadata only
Secrecy, Monopoly, and Access to Pharmaceuticals in International Trade Law: Protection of Marketing Approval Data Under the TRIPs Agreement
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- IP, Competition Law and Access to Pharmaceuticals: the Relevance of a "Market Approach" to the Exercise of IPRs, Paper prepared in the framework of the 2013 WTO-WIPO Colloquium for Teachers of Intellectual Property#1181289
- Legal Analysis of The Boycott of Global Products as A Form of Political Pressure in International Trade#212723
- Reconciling the global public health interest with intellectual property protection through the waiver of certain provisions of the WTO TRIPS Agreement#1042617
- The Effects of TRIPs on developing countries with particular emphasiss on the pharmaceutical Industry#956612
- Preempting Pre-Approval: Clarifying Preemption Doctrine for Product-Liability Suits Against Brand-Name Drug Manufacturers#477429
Record · ID 462101
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive